KPMG's latest report on China's life science sector notes that the country is set to become a crucial player in the life science and healthcare industry. Within a decade it is expected to become a global leader in drug discovery and innovation.
This report makes a compelling read for any organisation that is either planning or implementing a cloud strategy, and provides some practical and actionable advice for enterprises and their executives.
A guide which focuses on strategic priorities that have been driving FS companies to dispose and acquire, while pinning down the key factors that can distinguish between successful transactions from potential and actual failures.
Related links
RSS feeds
Subscribe to receive email alerts or e-Newsletters from KPMG China when new updates are available.